Press/Media
- 1 results
Search results
-
Phase 1 Study to Evaluate the Safety, Feasibility and Immunogenicity of an Allogeneic, Cell-based Vaccine (DCP-001) in High Grade Serous Ovarian Cancer Patients After Primary Treatment (ALISON)
04/02/2021
2 Media contributions
Press/Media: Expert Comment › Popular